Old migraine drug gets new shot at healing spinal injuries

NCT ID NCT06677229

Recruiting now Disease control Sponsor: Technophage, SA Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing whether a migraine medication called Eletriptan can help people recover function after a recent spinal cord injury. Researchers will give the drug to 28 adults with thoracic spinal injuries within 24 hours of their injury to see if it's safe and if it improves movement. The study repurposes a drug with 20 years of safety history to potentially help the nervous system heal.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Universitario La Paz
RECRUITING

Madrid, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hospital Universitario Reina Sofia
RECRUITING

Córdoba, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE SPINAL CORD INJURY (SCI)